APA (7th ed.) Citation

Karime, C., Odah, T., Hashash, J. G., Pardi, D. S., Khanna, S., & Farraye, F. A. (2026). Bezlotoxumab for prevention of Clostridioides difficile recurrence in patients with inflammatory bowel disease: A retrospective multicenter experience. Annals of Gastroenterology, 39(1), 114. https://doi.org/10.20524/aog.2026.1029

Chicago Style (17th ed.) Citation

Karime, Christian, Tarek Odah, Jana G. Hashash, Darrell S. Pardi, Sahil Khanna, and Francis A. Farraye. "Bezlotoxumab for Prevention of Clostridioides Difficile Recurrence in Patients with Inflammatory Bowel Disease: A Retrospective Multicenter Experience." Annals of Gastroenterology 39, no. 1 (2026): 114. https://doi.org/10.20524/aog.2026.1029.

MLA (9th ed.) Citation

Karime, Christian, et al. "Bezlotoxumab for Prevention of Clostridioides Difficile Recurrence in Patients with Inflammatory Bowel Disease: A Retrospective Multicenter Experience." Annals of Gastroenterology, vol. 39, no. 1, 2026, p. 114, https://doi.org/10.20524/aog.2026.1029.